GGrantIndex
Sort

166,118 grants matching stem cells

Genetic and Biochemical Approaches to Tyrosine Kinase Function

$2,080,841
Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2009 · HG

Off-the-Shelf Immune Effector Cells for Hematological Malignancies

$2,080,518
John E Wagner · University Of Minnesota · P01 · FY2025 · CA

Mechanisms and Markers of Prostate Cancer Metastases

$2,080,291
Robert Vessella · University Of Washington · P01 · FY2012 · CA

Biology & Transplantation of the Human Stem Cell

$2,080,053
Philip McGlave · University Of Minnesota · P01 · FY2008 · CA

Infrastructure for Trans-NIH Imaging Initiative: Imaging from Molecules to Cells

$2,079,817
Richard Leapman · National Institute Of Biomedical Imaging And Bioengineering · Z01 · FY2008 · EB

Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.

$2,079,438
Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL

Cell Adhesion Mechanisms in Vascular Disease & Thrombosis

$2,078,983
Mark Howard Ginsberg · University Of California, San Diego · P01 · FY2007 · HL

YALE COMPREHENSIVE CANCER CENTER

$2,078,823
Yale University · P30 · FY2002 · CA

Novel Therapeutic Approaches for Parkinson's Disease

$2,078,654
Ole Isacson · Mclean Hospital · P50 · FY2009 · NS

Targeted Sphingolipid Metabolism for Treatment of AML

$2,077,502
Thomas P Loughran · University Of Virginia · P01 · FY2015 · CA

Structure and function of eukaryotic DNA transposases

$2,077,429
Fred Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

Pathophysiology and Treatment of Fanconi's Anemia

$2,077,422
Markus Grompe · Oregon Health & Science University · P01 · FY2012 · HL

Paneth cell mitochondria and intestinal homeostasis

$2,076,999
Arianne L Theiss · University Of Colorado Denver · R01 · FY2025 · DK

NHLBI Transgenic Core

$2,076,981
Chengyu Liu · National Heart, Lung, And Blood Institute · ZIC · FY2022 · HL

Characterizing Emerging Humanized Immune Mouse Models for the study of transplant rejection and infectious disease pathology (Epstein Barr Virus)

$2,076,613
Matthew E Brown · University Of Wisconsin-Madison · N01 · FY2021 · AI

Alterations In Lipid Metabolism In The Nervous System By Ethanol

$2,076,604
Hee-Yong Kim · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA

Endothelial Cell Phenotypes in Health and Disease

$2,076,597
William C Aird · Beth Israel Deaconess Medical Center · P01 · FY2012 · HL

Engineered bone marrow niche to reconstitute T cell immunity

$2,076,253
David T Scadden · Harvard University · U54 · FY2019 · CA

SPORE for Translational Approaches to Brain Cancer

$2,076,151
Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2024 · CA

Hematopoietic Stem Cells for Transplantation

$2,075,973
Saul J Sharkis · Johns Hopkins University · P01 · FY2012 · CA

From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motor

$2,075,915
Daniel Bernstein · Stanford University · RM1 · FY2022 · GM

From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motor

$2,075,915
Daniel Bernstein · Stanford University · RM1 · FY2023 · GM

From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motor

$2,075,793
Daniel Bernstein · Stanford University · RM1 · FY2020 · GM

Hematopoietic Stem Cells for Transplantation

$2,075,614
Saul J Sharkis · Johns Hopkins University · P01 · FY2011 · CA

Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge

$2,074,913
Brenda Marie Sandmaier · Fred Hutchinson Cancer Center · P01 · FY2025 · CA